Skip to main content

Table 5 PPI consumption before surgery and at follow up visits

From: Non-active implantable device treating acid reflux with a new dynamic treatment approach: 1-year results

 

Number of subjects (n)

Total

n (%)

PPI use related to acid reflux

PPI use related to malfunction of the treatment principle of RefluxStop™

Regular daily PPI consumption

 Baseline

50

50 (100%)

50 (100%)

50 (100%)

 6 Months

47

0 (0.0%)

0

0

 1 year

47

1 (2.1%)

1a

0

  1. aOne (1) subject with the device positioned too low, prohibiting the function of the device